![Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects - Hagelberg - 2016 - Pharmacology Research & Perspectives - Wiley Online Library Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects - Hagelberg - 2016 - Pharmacology Research & Perspectives - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/2e083773-2249-4db3-843d-28120f41d51a/prp2271-fig-0001-m.jpg)
Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects - Hagelberg - 2016 - Pharmacology Research & Perspectives - Wiley Online Library
![Table 2 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ... Table 2 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ...](https://d3i71xaburhd42.cloudfront.net/54f8d67c7def66564e230bcb8c3a2b37e01316fc/7-Table4-1.png)
Table 2 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ...
![Table 2 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ... Table 2 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ...](https://d3i71xaburhd42.cloudfront.net/54f8d67c7def66564e230bcb8c3a2b37e01316fc/6-Table2-1.png)
Table 2 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ...
![Table 3 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ... Table 3 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ...](https://d3i71xaburhd42.cloudfront.net/54f8d67c7def66564e230bcb8c3a2b37e01316fc/6-Table3-1.png)
Table 3 from A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain ...
![An image of a Box of Temgesic 200 micrograms sub lingual tablets for the treatment of acute and chronic pain relief Stock Photo - Alamy An image of a Box of Temgesic 200 micrograms sub lingual tablets for the treatment of acute and chronic pain relief Stock Photo - Alamy](https://c8.alamy.com/zooms/9/b6a3ef6bb0954a50ae6bfec98fb0eec4/2fkjbda.jpg)